Stay updated on Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial

Sign up to get notified when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    No additions or deletions detected on the page; the study details and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T21:03:37.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T05:27:20.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:08.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-14T19:12:21.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T15:33:06.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of various chemical compounds and proteins, as well as a new facility name and location details. Notably, previous entries related to specific antineoplastic agents and their classifications have been removed.
    Difference
    3%
    Check dated 2025-08-31T11:58:28.000Z thumbnail image

Stay in the know with updates to Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.